Taken together these data summarized the main findings characterizing the drug induced acute hemolysis in subjects with G6PD deficiency, supporting the role of Fyn as key regulator of G6PD activity in red cells [19,37]. This evidence concerns the gene G6PD and G6PD deficiency.